The LARA trial (NCT04699071), a multi-center, single-arm, phase 2 study, found that combining pembrolizumab (Keytruda) with ...
14hon MSN
Church information for Jan. 31
Here is church information for Jan. 31.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results